Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
Endocrine · 2024
DOI: 10.1007/s12020-024-04052-3 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Endocrine, 2024. Verfasst von Francinny Alves Kelly und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hypertension, Dante Pazzanese Institute of Cardiology, São Paulo, São Paulo, Brazil. francinnyalveskelly@gmail.com. Hauptthemen laut MEDLINE: Metformin, Polycystic Ovary Syndrome, Inositol, Hypoglycemic Agents. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Metformin was the first medication targeting insulin resistance in PCOS, and it has been extensively studied as a metabolic treatment option. In recent years, inositols have emerged as potential treatment options for PCOS, but confidence in the available evidence supporting their use is limited. METHODS: We comprehensively searched PubMed, Embase, and Cochrane databases for RCTs comparing the use of combined metformin and inositol versus metformin alone in women with PCOS. A random-effects model was used to calculate the risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs). A p-value of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hypertension, Dante Pazzanese Institute of Cardiology, São Paulo, São Paulo, Brazil. francinnyalveskelly@gmail.com.
- Center of Medical Sciences, Federal University of Pernambuco, Recife, Pernambuco, Brazil.
- Department of Medicine, University of Pernambuco, Recife, Pernambuco, Brazil.
- Department of Medicine, Federal University of Pará, Belém, Pará, Brazil.
ORCID-Profile: Francinny Alves Kelly, Artur de Oliveira Macena Lôbo, Jorge Henrique Cavalcanti Orestes Cardoso, Francisco Cezar Aquino de Moraes
Zitieren
APA
Kelly, F. A., de Oliveira Macena Lôbo, A., Cardoso, J. H. C. O., & de Moraes, F. C. A. (2024). Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Endocrine. https://doi.org/10.1007/s12020-024-04052-3
Vancouver
Kelly FA, de Oliveira Macena Lôbo A, Cardoso JHCO, de Moraes FCA. Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Endocrine. 2024. doi:10.1007/s12020-024-04052-3
BibTeX
@article{Kelly2024,
author = {Kelly, Francinny Alves and de Oliveira Macena Lôbo, Artur and Cardoso, Jorge Henrique Cavalcanti Orestes and de Moraes, Francisco Cezar Aquino},
title = {Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials},
journal = {Endocrine},
year = {2024},
doi = {10.1007/s12020-024-04052-3}
}
EUVIMED